• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共存风险因素对急性冠状动脉综合征患者结局的影响:利用台湾长庚研究数据库进行的真实世界分析。

Impact of Coexisting Risk Factors on Outcomes in Patients with Acute Coronary Syndrome: A Real-World Analysis Using the Taiwan Chang Gung Research Database.

机构信息

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.

出版信息

Med Sci Monit. 2023 Aug 4;29:e941258. doi: 10.12659/MSM.941258.

DOI:10.12659/MSM.941258
PMID:37537861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10408345/
Abstract

BACKGROUND Diabetes mellitus (DM), chronic kidney disease (CKD), and advanced age are associated with poor outcomes in patients with acute coronary syndrome (ACS). This real-world study utilized data from the Taiwan Chang Gung Research Database (CGRD) to compare outcomes in ACS patients with DM, CKD, and the elderly. MATERIAL AND METHODS The study enrolled 28,613 ACS patients diagnosed based on CGRD medical records between January 2005 and December 2019. Baseline characteristics and clinical outcomes were compared among groups based on patient characteristics. RESULTS Within the ACS cohort, 42.1% had DM, 48.2% had CKD, and 33.6% were elderly. Among them, 10.7% (3,070) were elderly patients with both DM and CKD. Elderly patients with DM and CKD had significantly higher risks of gastrointestinal bleeding (hazard ratio=11.32), cardiovascular events (HR=7.29), and all-cause mortality (HR=8.59). Patients with three or at least two of these risk factors had a 2.20-2.99-fold increased risk of recurrent ACS during the three-year follow-up period. CONCLUSIONS Patients with the combination of DM, CKD, and advanced age (elderly) experienced an 11.32-fold increased risk of gastrointestinal bleeding, 7.29-fold increased risk of cardiovascular events, and 8.59-fold increased risk of all-cause mortality compared to those without these risk factors. Furthermore, patients with two or more of these risk factors had a 2- to 3-fold increased risk of recurrent ACS. These findings emphasize the importance of managing multiple risk factors in ACS patients to improve outcomes.

摘要

背景

糖尿病(DM)、慢性肾脏病(CKD)和高龄与急性冠状动脉综合征(ACS)患者的不良结局相关。本真实世界研究利用了来自台湾长庚研究数据库(CGRD)的数据,比较了伴有 DM、CKD 和高龄的 ACS 患者的结局。

材料与方法

该研究纳入了 2005 年 1 月至 2019 年 12 月期间根据 CGRD 病历诊断为 ACS 的 28613 例患者。根据患者特征比较了各组间的基线特征和临床结局。

结果

在 ACS 队列中,42.1%有 DM,48.2%有 CKD,33.6%为高龄。其中,10.7%(3070 例)为同时患有 DM 和 CKD 的高龄患者。患有 DM 和 CKD 的高龄患者发生胃肠道出血(风险比=11.32)、心血管事件(HR=7.29)和全因死亡率(HR=8.59)的风险显著更高。在三年随访期间,具有三种或至少两种这些风险因素的患者复发 ACS 的风险增加 2.20-2.99 倍。

结论

与无这些风险因素的患者相比,同时患有 DM、CKD 和高龄(老年)的患者发生胃肠道出血的风险增加 11.32 倍,发生心血管事件的风险增加 7.29 倍,全因死亡率的风险增加 8.59 倍。此外,具有两种或更多这些风险因素的患者复发 ACS 的风险增加 2-3 倍。这些发现强调了在 ACS 患者中管理多种风险因素以改善结局的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/25287fa2b514/medscimonit-29-e941258-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/c64cab8c52d8/medscimonit-29-e941258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/c18f57795238/medscimonit-29-e941258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/95f1fb76b259/medscimonit-29-e941258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/25287fa2b514/medscimonit-29-e941258-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/c64cab8c52d8/medscimonit-29-e941258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/c18f57795238/medscimonit-29-e941258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/95f1fb76b259/medscimonit-29-e941258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a601/10408345/25287fa2b514/medscimonit-29-e941258-g004.jpg

相似文献

1
Impact of Coexisting Risk Factors on Outcomes in Patients with Acute Coronary Syndrome: A Real-World Analysis Using the Taiwan Chang Gung Research Database.共存风险因素对急性冠状动脉综合征患者结局的影响:利用台湾长庚研究数据库进行的真实世界分析。
Med Sci Monit. 2023 Aug 4;29:e941258. doi: 10.12659/MSM.941258.
2
Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort study.糖尿病和慢性肾脏病对急性冠状动脉综合征风险的单独及联合影响:一项基于人群的队列研究。
Medicine (Baltimore). 2014 Dec;93(28):e261. doi: 10.1097/MD.0000000000000261.
3
Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease.当代急性冠状动脉综合征合并糖尿病或慢性肾脏病患者抗血小板药物的使用趋势。
Pharmacotherapy. 2017 Oct;37(10):1322-1327. doi: 10.1002/phar.2018. Epub 2017 Sep 19.
4
Additive effect of in-hospital TIMI bleeding and chronic kidney disease on 1-year cardiovascular events in patients with acute coronary syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry.院内TIMI出血与慢性肾脏病对急性冠脉综合征患者1年心血管事件的叠加效应:来自台湾急性冠脉综合征全谱注册研究的数据
Heart Vessels. 2015 Jul;30(4):441-50. doi: 10.1007/s00380-014-0504-9. Epub 2014 May 7.
5
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.慢性肾脏病与经皮冠状动脉介入治疗的急性冠状动脉综合征患者使用普拉格雷与氯吡格雷治疗结局的相关性:来自 PROMETHEUS 研究的报告。
JACC Cardiovasc Interv. 2017 Oct 23;10(20):2017-2025. doi: 10.1016/j.jcin.2017.02.047. Epub 2017 Aug 2.
6
Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.慢性肾脏病和糖尿病与接受经皮冠状动脉介入治疗患者的长期预后相关。
BMC Cardiovasc Disord. 2017 Sep 11;17(1):242. doi: 10.1186/s12872-017-0673-4.
7
Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding.糖尿病和慢性肾脏病并存对肝硬化合并食管静脉曲张出血患者死亡率的影响。
BMC Gastroenterol. 2016 Feb 29;16:29. doi: 10.1186/s12876-016-0434-3.
8
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.糖尿病和慢性肾脏病对急性冠状动脉综合征患者心血管结局和血小板 P2Y 受体拮抗剂作用的影响:来自 PLATO 试验的见解。
J Am Heart Assoc. 2019 Mar 19;8(6):e011139. doi: 10.1161/JAHA.118.011139.
9
Influenza Vaccination is Associated with Lower Risk of Acute Coronary Syndrome in Elderly Patients with Chronic Kidney Disease.流感疫苗接种与老年慢性肾脏病患者急性冠状动脉综合征风险降低相关。
Medicine (Baltimore). 2016 Feb;95(5):e2588. doi: 10.1097/MD.0000000000002588.
10
The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.新诊断糖尿病患者中与慢性肾脏病相关的不同心血管疾病发病率的风险轨迹:倾向评分匹配队列分析。
Cardiovasc Diabetol. 2021 Apr 24;20(1):86. doi: 10.1186/s12933-021-01279-6.

本文引用的文献

1
Ticagrelor Versus Clopidogrel in East Asian Patients With Acute Coronary Syndrome and Diabetes Mellitus.替格瑞洛与氯吡格雷在东亚急性冠状动脉综合征合并糖尿病患者中的比较
JACC Asia. 2022 Nov 15;2(6):666-674. doi: 10.1016/j.jacasi.2022.07.005. eCollection 2022 Nov.
2
The Relationship of Conduction Disorder and Prognosis in Patients with Acute Coronary Syndrome.传导障碍与急性冠状动脉综合征患者预后的关系。
Int J Clin Pract. 2022 Oct 22;2022:9676434. doi: 10.1155/2022/9676434. eCollection 2022.
3
Predictors of gastrointestinal bleeding in patients following left ventricular assist device implantation: a systematic review and meta-analysis.
左心室辅助装置植入术后患者胃肠道出血的预测因素:一项系统评价和荟萃分析。
Future Cardiol. 2022 Dec;18(12):957-967. doi: 10.2217/fca-2022-0054. Epub 2022 Nov 5.
4
Predictors of In-Hospital Mortality in Patients with Acute Coronary Syndrome in Hasan Sadikin Hospital, Bandung, Indonesia: A Retrospective Cohort Study.印度尼西亚万隆哈桑萨迪金医院急性冠状动脉综合征患者住院死亡率的预测因素:一项回顾性队列研究。
Acta Med Indones. 2022 Jul;54(3):379-388.
5
Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry.老年人群急性心肌梗死患者经皮冠状动脉介入治疗的预后:多中心前瞻性 e-ULTIMASTER 注册研究结果。
Clin Cardiol. 2022 Dec;45(12):1211-1219. doi: 10.1002/clc.23902. Epub 2022 Sep 7.
6
Systematic review and meta-analysis of prognostic models in Southeast Asian populations with acute myocardial infarction.东南亚急性心肌梗死患者预后模型的系统评价与荟萃分析。
Front Cardiovasc Med. 2022 Jul 26;9:921044. doi: 10.3389/fcvm.2022.921044. eCollection 2022.
7
Predictors of recurrent acute myocardial infarction despite successful percutaneous coronary intervention.经皮冠状动脉介入治疗成功后复发性急性心肌梗死的预测因素。
Korean J Intern Med. 2022 Jul;37(4):777-785. doi: 10.3904/kjim.2021.427. Epub 2022 Jun 28.
8
Incidence and predictors of serious bleeding during long-term follow-up after acute coronary syndrome in a population-based cohort study.基于人群队列研究的急性冠脉综合征长期随访后严重出血的发生率和预测因素。
Sci Rep. 2021 Nov 9;11(1):21967. doi: 10.1038/s41598-021-01525-7.
9
Impact of high triglyceride/high-density lipoprotein cholesterol ratio (insulin resistance) in ST-segment elevation myocardial infarction.高甘油三酯/高密度脂蛋白胆固醇比值(胰岛素抵抗)对ST段抬高型心肌梗死的影响。
Medicine (Baltimore). 2020 Oct 23;99(43):e22848. doi: 10.1097/MD.0000000000022848.
10
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.